Is CTCXW or MRK a better dividend investment in 2026?

CTCXW currently yields 7490.64% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CTCXW offers higher current income.

What is the dividend yield difference between CTCXW and MRK?

CTCXW has a forward dividend yield of 7490.64% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 7487.88 percentage points.

Home › Compare › CTCXW vs MRK

CTCXW vs MRK: Dividend Comparison 2026

CTCXW yields 7490.64% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CTCXW wins by $3219325239215192.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CTCXW

● Live price

7490.64%

Share price

$0.03

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3219325239215192.50M

Annual income

$3,136,944,464,329,217,000,000.00

Full CTCXW calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CTCXW vs MRK

📍 CTCXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CTCXW	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CTCXW + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CTCXW pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCXW

Annual income on $10K today (after 15% tax)

$636,704.12/yr

After 10yr DRIP, annual income (after tax)

$2,666,402,794,679,834,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CTCXW beats the other by $2,666,402,794,679,834,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCXW + MRK for your $10,000?

CTCXW: 50%MRK: 50%

100% MRK50/50100% CTCXW

Portfolio after 10yr

$1609662619607596.25M

Annual income

$1,568,472,232,164,608,400,000.00/yr

Blended yield

97.44%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CTCXW

No analyst data

Altman Z

-38.0

Piotroski

4/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCXW buys

MRK buys

No recent congressional trades found for CTCXW or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCTCXWMRK

Forward yield	7490.64% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$3219325239215192.50M ✓	$56.8K
Annual income after 10y	$3,136,944,464,329,217,000,000.00 ✓	$9,798.13
Total dividends collected	$3213812604182292.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CTCXW vs MRK ($10,000, DRIP)

Year	CTCXW Portfolio	CTCXW Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$759,764	$749,063.67	$11,206	$366.19	+$748.6K → CTCXW
2	$54,000,925	$53,187,977.91	$12,650	$502.35	+$53.99M → CTCXW
3	$3,590,852,097	$3,533,071,107.68	$14,407	$694.19	+$3590.84M → CTCXW
4	$223,408,125,107	$219,565,913,362.68	$16,585	$967.82	+$223408.11M → CTCXW
5	$13,005,862,347,544	$12,766,815,653,679.31	$19,342	$1,363.89	+$13005862.33M → CTCXW
6	$708,523,022,229,903	$694,606,749,518,031.20	$22,913	$1,947.19	+$708523022.21M → CTCXW
7	$36,122,824,222,390,480	$35,364,704,588,604,476.00	$27,662	$2,823.89	+$36122824222.36M → CTCXW
8	$1,723,706,063,164,109,000	$1,685,054,641,246,151,400.00	$34,159	$4,173.35	+$1723706063164.07M → CTCXW
9	$76,991,378,398,107,710,000	$75,147,012,910,522,120,000.00	$43,337	$6,308.80	+$76991378398107.67M → CTCXW
10	$3,219,325,239,215,192,500,000	$3,136,944,464,329,217,000,000.00	$56,776	$9,798.13	+$3219325239215192.50M → CTCXW

CTCXW vs MRK: Complete Analysis 2026

CTCXW — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCXW Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CTCXW vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCXW vs SCHD CTCXW vs JEPI CTCXW vs O CTCXW vs KO CTCXW vs MAIN CTCXW vs JNJ CTCXW vs ABBV CTCXW vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.